Business Description
Tauns Laboratories Inc
ISIN : JP3452250008
Description
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.99 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.7 | |||||
| Debt-to-EBITDA | 1.12 | |||||
| Interest Coverage | 257.28 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.49 | |||||
| Beneish M-Score | -3.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.99 | |||||
| 9-Day RSI | 58.61 | |||||
| 14-Day RSI | 55.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.61 | |||||
| Quick Ratio | 1.16 | |||||
| Cash Ratio | 0.9 | |||||
| Days Inventory | 286.03 | |||||
| Days Sales Outstanding | 57 | |||||
| Days Payable | 80.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.89 | |||||
| Dividend Payout Ratio | 0.2 | |||||
| Forward Dividend Yield % | 3.19 | |||||
| 5-Year Yield-on-Cost % | 1.89 | |||||
| Shareholder Yield % | -3.53 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.8 | |||||
| Operating Margin % | 43.56 | |||||
| Net Margin % | 31.32 | |||||
| FCF Margin % | 32.41 | |||||
| ROE % | 52.12 | |||||
| ROA % | 24.26 | |||||
| ROIC % | 34.85 | |||||
| ROC (Joel Greenblatt) % | 76.81 | |||||
| ROCE % | 51.41 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.55 | |||||
| PE Ratio without NRI | 10.55 | |||||
| PS Ratio | 3.32 | |||||
| PB Ratio | 4.17 | |||||
| Price-to-Tangible-Book | 5.67 | |||||
| Price-to-Free-Cash-Flow | 10.19 | |||||
| Price-to-Operating-Cash-Flow | 6.13 | |||||
| EV-to-EBIT | 7.24 | |||||
| EV-to-EBITDA | 6.69 | |||||
| EV-to-Revenue | 3.1 | |||||
| EV-to-FCF | 9.56 | |||||
| Price-to-Graham-Number | 1.62 | |||||
| Price-to-Net-Current-Asset-Value | 42.69 | |||||
| Earnings Yield (Greenblatt) % | 13.8 | |||||
| FCF Yield % | 10.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tauns Laboratories Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 18,434.863 | ||
| EPS (TTM) (円) | 53.99 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 55.58 | ||
| 14-Day ATR (円) | 18.934155 | ||
| 20-Day SMA (円) | 548.6 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (円) | 401 - 653 | ||
| Shares Outstanding (Mil) | 100.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tauns Laboratories Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tauns Laboratories Inc Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tauns Laboratories Inc Frequently Asked Questions
What is Tauns Laboratories Inc(TSE:197A)'s stock price today?
The current price of TSE:197A is 円564.00. The 52 week high of TSE:197A is 円653.00 and 52 week low is 円401.00.
When is next earnings date of Tauns Laboratories Inc(TSE:197A)?
The next earnings date of Tauns Laboratories Inc(TSE:197A) is .
Does Tauns Laboratories Inc(TSE:197A) pay dividends? If so, how much?
The Dividend Yield %  of Tauns Laboratories Inc(TSE:197A) is 1.89% (As of Today), Highest Dividend Payout Ratio of Tauns Laboratories Inc(TSE:197A) was 0.2. The lowest was 0.2. And the median was 0.2. The  Forward Dividend Yield % of Tauns Laboratories Inc(TSE:197A) is 3.19%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers